RUNX proteins bind the p14-ARF promoter at the CDKN2A locus

Stable Identifier
R-HSA-8952081
Type
Reaction [binding]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The CDKN2A gene promoter that regulates transcription of p14-ARF contains Runx response elements that are known to be recognized by the RUNX1:CBFB complex (Linggi et al. 2002). Based on sequence similarity between RUNX1 and RUNX3 and the fact that the complex of acetylated RUNX3 and BRD2 positively regulate p14-ARF transcription, it is possible that RUNX3 can also bind to the Runx response elements at the p14-ARF promoter (Lee et al. 2013).
Literature References
PubMed ID Title Journal Year
24229708 Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma

Lee, JW, Lee, YS, Chuang, LS, Kim, JH, Bae, SC, Jang, JW, Ito, Y, Suh, JW, Chi, XZ, Chung, JH, Choi, BS, Lee, OJ, Li, YH, Kim, EG, Kim, DM, Lee, YM, Kim, MK

Cancer Cell 2013
12091906 The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia

Berdel, WE, Serve, H, Nip, J, van der Reijden, B, Linggi, B, Hiebert, SW, Hu, M, Cleveland, J, Rowley, JD, Quelle, DE, Müller-Tidow, C, van de Locht, L, Pandolfi, PP, Jansen, JH

Nat. Med. 2002
Participants
Participates
Authored
Reviewed
Created
Cite Us!